Back to All NewsAllergan is buying CoolSculpting provider Zeltiq for $2.48 billion
Posted By American Med Spa Association, Tuesday, February 14, 2017
Share
Botox maker Allergan is spending about $2.48 billion to buy Zeltiq Aesthetics Inc. and its CoolSculpting system for reducing fat.
Allergan said it will pay $56.50 for each share of Zeltiq in a deal it expects to close in the second half of this year. That represents a 14% premium to Zeltiq's Friday closing price of $49.40. The Pleasanton, Calif., company's shares jumped 13.2% on Monday to $55.93.
Allergan, based in Dublin, Ireland, said the deal will strengthen an aesthetics business that already includes plastic surgery and regenerative treatments.
Zeltiq's nonsurgical system cools fat cells to trigger their controlled elimination without affecting the surrounding tissue, according to Allergan.
Read more at Los Angeles Times >>
Allergan said it will pay $56.50 for each share of Zeltiq in a deal it expects to close in the second half of this year. That represents a 14% premium to Zeltiq's Friday closing price of $49.40. The Pleasanton, Calif., company's shares jumped 13.2% on Monday to $55.93.
Allergan, based in Dublin, Ireland, said the deal will strengthen an aesthetics business that already includes plastic surgery and regenerative treatments.
Zeltiq's nonsurgical system cools fat cells to trigger their controlled elimination without affecting the surrounding tissue, according to Allergan.
Read more at Los Angeles Times >>
